Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study.
Crohn's disease
USMI
bioelectrical impedance analysis
diagnostic tools
disease activity
magnetic resonance imaging
malnutrition
ulcerative colitis
ultrasound muscle index
Journal
United European gastroenterology journal
ISSN: 2050-6414
Titre abrégé: United European Gastroenterol J
Pays: England
ID NLM: 101606807
Informations de publication
Date de publication:
28 Mar 2024
28 Mar 2024
Historique:
received:
10
12
2023
accepted:
08
03
2024
medline:
29
3
2024
pubmed:
29
3
2024
entrez:
29
3
2024
Statut:
aheadofprint
Résumé
Sarcopenia is prevalent in patients with inflammatory bowel disease (IBD) and impacts surgical and therapeutic outcomes; thus, effective diagnostic tools are needed to assess muscle mass and function in this population. 153 consecutive patients were included, 100 in the training cohort and 53 in the study cohort. Three superficial muscles (rectus femoris = RF, rectus abdominis = RA, and biceps brachii = BB) were selected for the detection of sarcopenia using muscle ultrasound (US). The training cohort consisted of consecutive patients with or without IBD and was used to evaluate the feasibility and inter- and intra-observer variability of the US measurement. The study cohort consisted of only IBD patients and served to test US diagnostic accuracy. In the latter, muscle US, bioelectrical impedance analysis (BIA), and magnetic resonance imaging (MRI) were used to measure muscle parameters. Sarcopenia prevalence in IBD patients was 50%. Muscle US showed excellent inter-rater and intra-rater reliability (ICC >0.95) and a good diagnostic accuracy in detecting sarcopenia compared to BIA with area under the receiver operating characteristic curve (AUROC) values of 80% and 85% for RA and BB thickness, respectively. Moreover, an Ultrasound Muscle Index (USMI) was defined as the sum of the RA, BB, and RF thickness divided by the square of the patient's height, resulting in an AUROC of 81%. Muscle thresholds for sarcopenia were detected, with RA and USMI values correlated with the highest positive (84.3%) and negative (99%) predictive values, respectively. Additionally, the agreement between the US and MRI measurements of RA was excellent (ICC 0.96). The findings of this study emphasize the potential of muscle US as a reliable diagnostic tool for assessing sarcopenia in IBD patients. This research has significant implications for disease management in IBD patients and underscores the need for further investigations to validate these findings in larger cohorts.
Sections du résumé
BACKGROUND
BACKGROUND
Sarcopenia is prevalent in patients with inflammatory bowel disease (IBD) and impacts surgical and therapeutic outcomes; thus, effective diagnostic tools are needed to assess muscle mass and function in this population.
METHODS
METHODS
153 consecutive patients were included, 100 in the training cohort and 53 in the study cohort. Three superficial muscles (rectus femoris = RF, rectus abdominis = RA, and biceps brachii = BB) were selected for the detection of sarcopenia using muscle ultrasound (US). The training cohort consisted of consecutive patients with or without IBD and was used to evaluate the feasibility and inter- and intra-observer variability of the US measurement. The study cohort consisted of only IBD patients and served to test US diagnostic accuracy. In the latter, muscle US, bioelectrical impedance analysis (BIA), and magnetic resonance imaging (MRI) were used to measure muscle parameters.
RESULTS
RESULTS
Sarcopenia prevalence in IBD patients was 50%. Muscle US showed excellent inter-rater and intra-rater reliability (ICC >0.95) and a good diagnostic accuracy in detecting sarcopenia compared to BIA with area under the receiver operating characteristic curve (AUROC) values of 80% and 85% for RA and BB thickness, respectively. Moreover, an Ultrasound Muscle Index (USMI) was defined as the sum of the RA, BB, and RF thickness divided by the square of the patient's height, resulting in an AUROC of 81%. Muscle thresholds for sarcopenia were detected, with RA and USMI values correlated with the highest positive (84.3%) and negative (99%) predictive values, respectively. Additionally, the agreement between the US and MRI measurements of RA was excellent (ICC 0.96).
CONCLUSIONS
CONCLUSIONS
The findings of this study emphasize the potential of muscle US as a reliable diagnostic tool for assessing sarcopenia in IBD patients. This research has significant implications for disease management in IBD patients and underscores the need for further investigations to validate these findings in larger cohorts.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.
Références
Liu S, Ding X, Maggiore G, Pietrobattista A, Satapathy SK, Tian Z, et al. Sarcopenia is associated with poor clinical outcomes in patients with inflammatory bowel disease: a prospective cohort study. Ann Transl Med. 2022;10(6):367. https://doi.org/10.21037/atm‐22‐1126
Skrzypczak D, Ratajczak AE, Szymczak‐Tomczak A, Dobrowolska A, Eder P, Krela‐Kaźmierczak I. A vicious cycle of osteosarcopeniain inflammatory bowel diseases‐aetiology, clinical implications and therapeutic perspectives. Nutrients. 2021;13(2):293. https://doi.org/10.3390/nu13020293
Ding NS, Malietzis G, Lung PFC, Penez L, Yip WM, Gabe S, et al. The body composition profile is associated with response to anti‐TNF therapy in Crohn’s disease and may offer an alternative dosing paradigm. Aliment Pharmacol Ther. 2017;46(9):883–891. https://doi.org/10.1111/apt.14293
Cruz‐Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. https://doi.org/10.1093/ageing/afy169
Rezende IFB, Conceição‐Machado MEP, Souza VS, Santos EMD, Silva LR. Sarcopenia in children and adolescents with chronic liver disease. J Pediatr. 2020;96(4):439–446. https://doi.org/10.1016/j.jped.2019.02.005
Bryant RV, Ooi S, Schultz CG, Goess C, Grafton R, Hughes J, et al. Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41(9):895–906. https://doi.org/10.1111/apt.13156
Dhaliwal A, Quinlan JI, Overthrow K, Greig C, Lord JM, Armstrong MJ, et al. Sarcopenia in inflammatory bowel disease: a narrative overview. Nutrients. 2021;13(2):656. https://doi.org/10.3390/nu13020656
Massironi S, Viganò C, Palermo A, Pirola L, Mulinacci G, Allocca M, et al. Inflammation and malnutrition in inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2023;8(6):579–590. https://doi.org/10.1016/s2468‐1253(23)00011‐0
Adams DW, Gurwara S, Silver HJ, Horst SN, Beaulieu DB, Schwartz DA, et al. Sarcopenia is common in overweight patients with inflammatory bowel disease and may predict need for surgery. Inflamm Bowel Dis. 2017;23(7):1182–1186. https://doi.org/10.1097/mib.0000000000001128
Bischoff SC, Bager P, Escher J, Forbes A, Hébuterne X, Hvas CL, et al. ESPEN guideline on Clinical Nutrition in inflammatory bowel disease. Clin Nutr. 2023;42(3):352–379. https://doi.org/10.1016/j.clnu.2022.12.004
Gold SL, Raman M, Sands BE, Ungaro R, Sabino J. Review article: putting some muscle into sarcopenia‐the pathogenesis, assessment and clinical impact of muscle loss in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2023;57(11):1216–1230. https://doi.org/10.1111/apt.17498
Fiorindi C, Cuffaro F, Piemonte G, Cricchio M, Addasi R, Dragoni G, et al. Effect of long‐lasting nutritional prehabilitation on postoperative outcome in elective surgery for IBD. Clin Nutr. 2021;40(3):928–935. https://doi.org/10.1016/j.clnu.2020.06.020
Pizzoferrato M, de Sire R, Ingravalle F, Mentella MC, Petito V, Martone AM, et al. Characterization of sarcopenia in an IBD population attending an Italian gastroenterology tertiary center. Nutrients. 2019;11(10):2281. https://doi.org/10.3390/nu11102281
Molnár A, Csontos ÁA, Kovács I, Anton ÁD, Pálfi E, Miheller P. Body composition assessment of Crohn’s outpatients and comparison with gender‐ and age‐specific multiple matched control pairs. Eur J Clin Nutr. 2017;71(10):1246–1250. https://doi.org/10.1038/ejcn.2017.99
Perkisas S, Bastijns S, Baudry S, Bauer J, Beaudart C, Beckwée D, et al. Application of ultrasound for muscle assessment in sarcopenia: 2020 SARCUS update. Eur Geriatr Med. 2021;12(1):45–59. https://doi.org/10.1007/s41999‐020‐00433‐9
Kobayashi K, Maruyama H, Kiyono S, Ogasawara S, Suzuki E, Ooka Y, et al. Application of transcutaneous ultrasonography for the diagnosis of muscle mass loss in patients with liver cirrhosis. J Gastroenterol. 2018;53(5):652–659. https://doi.org/10.1007/s00535‐017‐1378‐2
Artru F, Louvet A. Letter: the diagnostic value of ultrasound‐based versus CT‐based sarcopenia measurement in cirrhosis – authors’ reply. Aliment Pharmacol Ther. 2023;57(5):593–594. https://doi.org/10.1111/apt.17398
Abe T, Fujita E, Thiebaud RS, Loenneke JP, Akamine T. Ultrasound‐derived forearm muscle thickness is a powerful predictor for estimating DXA‐derived appendicular lean mass in Japanese older adults. Ultrasound Med Biol. 2016;42(9):2341–2344. https://doi.org/10.1016/j.ultrasmedbio.2016.05.008
Hari A, Berzigotti A, Štabuc B, Caglevič N. Muscle psoas indices measured by ultrasound in cirrhosis ‐ preliminary evaluation of sarcopenia assessment and prediction of liver decompensation and mortality. Dig Liver Dis. 2019;51(11):1502–1507. https://doi.org/10.1016/j.dld.2019.08.017
Stratton RJ, Hackston A, Longmore D, Dixon R, Price S, Stroud M, et al. Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the ‘malnutrition universal screening tool’ (‘MUST’) for adults. Br J Nutr. 2004;92(5):799–808. https://doi.org/10.1079/bjn20041258
Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28–36. https://doi.org/10.1002/jcsm.12048
McKay MJ, Baldwin JN, Ferreira P, Simic M, Vanicek N, Burns J, et al. Reference values for developing responsive functional outcome measures across the lifespan. Neurology. 2017;88(16):1512–1519. https://doi.org/10.1212/wnl.0000000000003847
Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2. https://doi.org/10.1016/j.jamda.2019.12.012
Kim KM, Jang HC, Lim S. Differences among skeletal muscle mass indices derived from height‐weight‐and body mass index‐adjusted models in assessing sarcopenia. Korean J Intern Med. 2016;31(4):643–650. https://doi.org/10.3904/kjim.2016.015
Sergi G, De Rui M, Veronese N, Bolzetta F, Berton L, Carraro S, et al. Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free‐living Caucasian older adults. Clin Nutr. 2015;34(4):667–673. https://doi.org/10.1016/j.clnu.2014.07.010
Kawakami R, Tanisawa K, Ito T, Usui C, Miyachi M, Torii S, et al. Fat‐free mass index as a surrogate marker of appendicular skeletal muscle mass index for low muscle mass screening in sarcopenia. J Am Med Dir Assoc. 2022;23(12):1955–1961. https://doi.org/10.1016/j.jamda.2022.08.016
Ge S, Du Q, Feng X, Liu Y, Wang H, Hai S, et al. Optimal cutoffs for the diagnosis of sarcopenia in older Chinese adults. Front Nutr. 2022;9:853323. https://doi.org/10.3389/fnut.2022.853323
Tandon P, Ney M, Irwin I, Ma MM, Gramlich L, Bain VG, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl. 2012;18(10):1209–1216. https://doi.org/10.1002/lt.23495
Carey EJ, Lai JC, Wang CW, Dasarathy S, Lobach I, Montano‐Loza AJ, et al. A multicenter study to define sarcopenia in patients with end‐stage liver disease. Liver Transpl. 2017;23(5):625–633. https://doi.org/10.1002/lt.24750
Altman DG. Practical statistics for medical research [Internet]. Chapman and Hall/CRC; 1990. https://www.taylorfrancis.com/books/9781000228816
Metz CE. Basic principles of ROC analysis. Semin Nucl Med. 1978;8(4):283–298. https://doi.org/10.1016/s0001‐2998(78)80014‐2
McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276–282. https://doi.org/10.11613/bm.2012.031
Lee CH, Yoon H, Oh DJ, Lee JM, Choi YJ, Shin CM, et al. The prevalence of sarcopenia and its effect on prognosis in patients with Crohn’s disease. Intest Res. 2020;18(1):79–84. https://doi.org/10.5217/ir.2019.00107
Bedard K, Taylor L, Rajabali N, Kroeker K, Halloran B, Meng G, et al. Handgrip strength and risk of malnutrition are associated with an increased risk of hospitalizations in inflammatory bowel disease patients. Therap Adv Gastroenterol. 2023;16:17562848231194395. https://doi.org/10.1177/17562848231194395
Massironi S, Sileri P, Danese S. Get fit: muscle health for Crohn’s disease surgical outcome optimization. Inflamm Bowel Dis. 2023:izad235. https://doi.org/10.1093/ibd/izad235